What question did this study set out to answer?

February 2, 2026Open Access

Downregulation of Cyclin Kinase Inhibitors p16 INK4a and p27 in Conjunctival Melanomas

Key Points

This research investigates the downregulation of cyclin kinase inhibitors p16INK4a and p27 in conjunctival melanoma and their implications for diagnosis.
Analyzed expression levels of p16INK4a and p27 in conjunctival melanoma samples.
Utilized histopathological techniques for differential diagnosis.
Explored mechanisms of p16INK4a downregulation including genomic and epigenetic factors.
p16INK4a and p27 were significantly reduced in conjunctival melanoma compared to conjunctival nevus.
Loss of p16INK4a involves various mechanisms: genomic, epigenetic, and post-translational.
Restoring p16 function may diminish the aggressiveness of conjunctival melanoma.

Abstract

p16INK4a and p27 are significantly downregulated in CJM and may help in the histopathological differential diagnosis between melanoma and conjunctival nevus. p16INK4a loss involves genomic, epigenetic, and post-translational mechanisms. Restoring p16 function may reduce CJM aggressiveness.

Downregulation of Cyclin Kinase Inhibitors p16 INK4a and p27 in Conjunctival Melanomas

Key Points

Abstract

Cite This Study